13.92 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
Avalo Therapeutics, Inc. Common Stock
AVTXNASDAQ • USD
14.20
↗ 0.28 (2.01%)
POST MARKET (AS OF 07:57 PM EDT)
Post Market
AS OF 07:57 PM EDT
14.20
↗ 0.28 (2.01%)
Market: CLOSED
Open?$14.75
High?$15.11
Low?$13.73
Prev. Close?$13.92
Volume?742.1K
Avg. Volume?822.4K
VWAP?$14.08
Rel. Volume?0.90x
Bid / Ask
Bid?$13.84 × 100
Ask?$13.93 × 400
Spread?$0.09
Midpoint?$13.89
Valuation & Ratios
Market Cap?317.2M
Shares Out?26.7M
Float?21.2M
Float %?86.6%
P/E Ratio?N/A
P/B Ratio?3.82
EPS?-$3.43
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?8.13Strong
Quick Ratio?8.13Strong
Cash Ratio?1.23Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score58/100
P/E?N/A▾
P/B?3.82FAIR▾
P/S?5,376.53HIGH▾
P/FCF?N/A▾
EV/EBITDA?-4.2CHEAP▾
EV/Sales?5,107.75HIGH▾
Returns & Efficiency
ROE?-94.2%WEAK▾
ROA?-67.2%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$301.4M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
Employees
33
Market Cap
317.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-11-13
Address
1500 LIBERTY RIDGE DRIVE
WAYNE, PA 19087
Phone: 410-522-8707
WAYNE, PA 19087
Phone: 410-522-8707